Parental Attitudes Towards Vaccination Against COVID-19 in China During Pandemic

References

• Tanne JH. Covid-19: FDA authorises Pfizer vaccine for children 12–15. BMJ. 2021;n1204. doi:10.1136/bmj.n1204
   Web of Science ®Google Scholar
• Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC. Acute covid-19 and multisystem inflammatory syndrome in children. BMJ. 2021;n385. doi:10.1136/bmj.n385
   Web of Science ®Google Scholar
• Schaffer DeRoo S, Pudalov NJ, Fu LY. Planning for a COVID-19 vaccination program. JAMA. 2020;323(24):2458. doi:10.1001/jama.2020.8711
   PubMed Web of Science ®Google Scholar
• Ke R, Sanche S, Romero-Severson E, Hengartner N. Estimating the reproductive number R0 of SARS-CoV-2 in the United States and eight European countries and implications for vaccination. Epidemiology. 2020. doi:10.1101/2020.07.31.20166298
   Google Scholar
• Velavan TP, Pollard AJ, Kremsner PG. Herd immunity and vaccination of children for COVID-19. Int J Infect Dis. 2020;98:14–15. doi:10.1016/j.ijid.2020.06.065
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(2):181–192. doi:10.1016/S1473-3099(20)30843-4
   PubMed Web of Science ®Google Scholar
• Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(6):803–812. doi:10.1016/S1473-3099(20)30987-7
   PubMed Web of Science ®Google Scholar
• Tanriover MD, Doğanay HL, Akova M, et al. Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, Phase 3 trial in Turkey. Lancet. 2021;398(10296):213–222. doi:10.1016/S0140-6736(21)01429-X
   PubMed Web of Science ®Google Scholar
• Jara A, Undurraga EA, González C, et al. Effectiveness of an inactivated SARS-CoV-2 vaccine in Chile. N Engl J Med. 2021;385(10):875–884. doi:10.1056/NEJMoa2107715
   PubMed Web of Science ®Google Scholar
• Ranzani OT, Hitchings MDT, Dorion M, et al. Effectiveness of the CoronaVac vaccine in older adults during a gamma variant associated epidemic of covid-19 in Brazil: test negative case-control study. BMJ. 2021;n2015. doi:10.1136/bmj.n2015
   Web of Science ®Google Scholar
• Han B, Song Y, Li C, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy children and adolescents: a double-blind, randomised, controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021;21(12):1645–1653. doi:10.1016/S1473-3099(21)00319-4
   PubMed Web of Science ®Google Scholar
• Bell S, Clarke R, Mounier-Jack S, Walker JL, Paterson P. Parents’ and guardians’ views on the acceptability of a future COVID-19 vaccine: a multi-methods study in England. Vaccine. 2020;38(49):7789–7798. doi:10.1016/j.vaccine.2020.10.027
   PubMed Web of Science ®Google Scholar
• Jeffs E, Lucas N, Walls T. CoVID ‐19: parent and caregiver concerns about reopening New Zealand schools. J Paediatr Child Health. 2021;57(3):403–408. doi:10.1111/jpc.15234
   Web of Science ®Google Scholar
• Zhang KC, Fang Y, Cao H, et al. Parental acceptability of COVID-19 vaccination for children under the age of 18 years: cross-sectional online survey. JMIR Pediatr Parent. 2020;3(2):e24827. doi:10.2196/24827
   PubMedGoogle Scholar
• Goldman RD, Yan TD, Seiler M, et al. Caregiver willingness to vaccinate their children against COVID-19: cross sectional survey. Vaccine. 2020;38(48):7668–7673. doi:10.1016/j.vaccine.2020.09.084
   PubMed Web of Science ®Google Scholar
• Choi SH, Jo YH, Jo KJ, Park SE. Pediatric and parents’ attitudes towards COVID-19 vaccines and intention to vaccinate for children. J Korean Med Sci. 2021;36(31):e227. doi:10.3346/jkms.2021.36.e227
   PubMed Web of Science ®Google Scholar
• Yılmaz M, Sahin MK. Parents’ willingness and attitudes concerning the COVID‐19 vaccine: a cross‐sectional study. Int J Clin Pract. 2021;75(9). doi:10.1111/ijcp.14364
   Web of Science ®Google Scholar
• Kaufman J, Ryan R, Walsh L, et al. Face-to-face interventions for informing or educating parents about early childhood vaccination. Cochrane Database Syst Rev. 2018;2018(5). doi:10.1002/14651858.CD010038.pub3
   Web of Science ®Google Scholar
• Williams SE. What are the factors that contribute to parental vaccine-hesitancy and what can we do about it? Hum Vaccin Immunother. 2014;10(9):2584–2596. doi:10.4161/hv.28596
   PubMed Web of Science ®Google Scholar
• Glanz JM, Kraus CR, Daley MF. Addressing parental vaccine concerns: engagement, balance, and timing. PLoS Biol. 2015;13(8):e1002227. doi:10.1371/journal.pbio.1002227
   PubMed Web of Science ®Google Scholar
• Du F, Chantler T, Francis MR, et al. Access to vaccination information and confidence/hesitancy towards childhood vaccination: a cross-sectional survey in China. Vaccines. 2021;9(3):201. doi:10.3390/vaccines9030201
   Web of Science ®Google Scholar
• Olson O, Berry C, Kumar N. Addressing parental vaccine hesitancy towards childhood vaccines in the United States: a systematic literature review of communication interventions and strategies. Vaccines. 2020;8(4):590. doi:10.3390/vaccines8040590
   PubMed Web of Science ®Google Scholar
• Ames HM, Glenton C, Lewin S. Parents’ and informal caregivers’ views and experiences of communication about routine childhood vaccination: a synthesis of qualitative evidence. Cochrane Database Syst Rev. 2017;2017(4). doi:10.1002/14651858.CD011787.pub2
   Web of Science ®Google Scholar
• Gowda C, Schaffer SE, Kopec K, Markel A, Dempsey AF. A pilot study on the effects of individually tailored education for MMR vaccine-hesitant parents on MMR vaccination intention. Hum Vaccin Immunother. 2013;9(2):437–445. doi:10.4161/hv.22821
   PubMed Web of Science ®Google Scholar
• Kempe A, Daley MF, McCauley MM, et al. Prevalence of parental concerns about childhood vaccines. Am J Prev Med. 2011;40(5):548–555. doi:10.1016/j.amepre.2010.12.025
   PubMed Web of Science ®Google Scholar